Jeannine DellaVecchia, 41, states she was prescribed copyright to deal with symptoms linked to insulin resistance due to congenital adrenal hyperplasia and polycystic ovary syndrome. The drug semaglutide accounted for an approximated 88% of new GLP-1 prescriptions prepared in 2023 and reviewe